The University of Chicago Header Logo

Connection

Michael R. Bishop to Drug Resistance

Back to Details
This is a "connection" page, showing publications Michael R. Bishop has written about Drug Resistance.
Michael R. Bishop
Connection Strength
0.105
Drug Resistance
  1. Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood. 2013 Apr 11; 121(15):2864-74.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.